Revenue grew 1.0% to 2,232.2 million (2007: 2,206.6 million). Revenue growth was positive across almost all the business, with favourable pricing and good organic volume increases, particularly in Food Ingredients USA and Nutritionals. Revenue growth was offset by the sale of the Group's Pigmeat business in March 2008 and the effect of currency translation. Like-for-like revenue grew 8.9%. Operating profit pre exceptional increased 15.7% to 134.1 million (2007: 115.8 million).
Operating margin pre exceptional increased 80 basis points to 6.0% (2007: 5.2%). All businesses in the Group increased margins in 2008 with the exception of Food Ingredients Ireland where the decline in global dairy markets resulted in a significant imbalance between market returns and raw material input costs.
Profit before tax pre exceptional grew 20.8% in the year to 120.3 million (2007: 99.5 million) driven by the first time contribution of Optimum and good organic growth in all business segments except Food Ingredients Ireland. Like-for-like profit before tax pre exceptional grew 21.4%.
Financing costs increased 3.8 million to 21.1 million (2007: 17.3 million) due mainly to the financing cost associated with the acquisition of Optimum. EBIT to net financing cost cover was 6.4 times in 2008 compared to 6.7 times in 2007. EBITDA to net financing cost cover was 7.9 times compared to 8.6 times in 2007.
| 2008 | 2007 | Change | |
|---|---|---|---|
| Revenue | 2,232.2m | 2,206.6m | Up 1.0% |
| Operating profit pre exceptional | 134.1m | 115.8m | Up 15.7% |
| Operating margin pre exceptional | 6.0% | 5.20% | Up 80 bps |
| Net financing costs | (21.1m) | (17.3m) | Up 3.8m |
| Share of results of Joint Ventures & Associates | 7.3m | 1.0m | Up 6.3m |
| Profit before tax pre exceptional | 120.3m | 99.5m | Up 20.8% |
| Taxation pre exceptional | (21.5m) | (16.4m) | Up 5.1m |
| Profit after tax pre exceptional | 98.7m | 83.1m | Up 18.8% |
| Exceptional items | (19.4m) | (22.8m) | Down 3.4m |
| Earnings per share | 26.76c | 20.42c | Up 31.0% |
| Adjusted earnings per share1 | 35.86c | 30.25c | Up 18.5% |
| Dividend per share in respect of the full year | 6.51c | 6.08c | Up 7.1% |
1: Before exceptional items and amortisation of intangibles (net of related tax)
In 2008, the average interest rate for the Group reduced by approximately 70 basis points to 5.1% primarily due to lower US dollar rates. The Group operates a policy of fixing a significant amount of its interest exposure with approximately 80% of the Group's net debt currently contracted at fixed interest rates for 2009 and approximately 70% contracted at fixed rates for 2010.
Glanbia's share of revenue from Joint Ventures & Associates increased 4.9% to 370.3 million (2007: 353.0 million) with strong growth in Southwest Cheese. Glanbia's share of profits post interest and tax grew strongly in 2008 to 7.3 million (2007: 1.0 million). Both Southwest Cheese and Glanbia Cheese improved profitability and margins. Nutricima, the Group's Nigerian joint venture, consolidated its market position in 2008 but it was not possible in a developing economy to pass on all of the increases in raw material costs and as a result profits and margins were below 2007.
The 2008 pre exceptional tax charge increased 5.1 million to 21.5 million (2007: 16.4 million), reflecting growth in international profits, which attract higher tax rates. The effective tax rate for the Group, excluding Joint Ventures & Associates, was 19.1% in 2008 (2007: 16.7%).
In 2008, Glanbia initiated a rationalisation programme costing 14.5 million. This is as a result of an imperative to remain cost competitive, particularly in relation to the effect the global economic downturn is having on consumer demand. This programme is mainly focused on the Consumer Foods, Agribusiness and Food Ingredients Ireland businesses and associated costs relate primarily to redundancy.
An exceptional charge of 3.9 million was incurred on finalising the Group's exit from its Pigmeat business announced in March 2008. A deferred taxation charge of 1.0 million arose in Glanbia Cheese due to a change in UK taxation legislation.
Total exceptional costs for 2008 amounted to 19.4 million (2007: 22.8 million). Exceptional costs in 2007 arose due to a provision for the exit from Pigmeat and restructuring costs incurred in Consumer Foods.
Earnings per share increased 31.0% to 26.8 cents (2007: 20.4 cents) due to higher profits and lower exceptional costs, relative to 2007. Adjusted earnings per share increased 18.5% to 35.86 cents (2007: 30.25 cents).
The Board is recommending a final dividend of 3.76 cents per share (2007: final dividend 3.58 cents per share), an increase of 5.0%. This brings the total dividend for the year to 6.51 cents per share (2007: 6.08 cents per share), representing a total increase of 7.1% for the year.
| 2008 | 2007 | |||||
|---|---|---|---|---|---|---|
| Revenue | Operating profit |
Operating margin |
Revenue | Operating profit |
Operating margin |
|
| 'm | 'm | % | 'm | 'm | % | |
| International | 1,489.2 | 82.5 | 5.5% | 1,403.2 | 85.2 | 6.1% |
| Ireland | 743.0 | 51.5 | 6.9% | 803.4 | 30.6 | 3.8% |
| Total | 2,232.2 | 134.1 | 6.0% | 2,206.6 | 115.8 | 5.2% |
| Joint Ventures & Associates | 370.3 | 17.0 | 4.6% | 353.0 | 5.9 | 1.7% |
| Group total | 2,602.5 | 151.1 | 5.8% | 2,559.6 | 121.7 | 4.8% |
International activities include Food Ingredients, in Ireland and the USA, and the Group's global Nutritionals business. Food Ingredients Ireland is included in international activities as the majority of its products are sold to international customers.
The Ireland division includes Consumer Foods and Agribusiness & Property.
Joint Ventures & Associates includes the Group's three key strategic joint ventures, which are Southwest Cheese, Glanbia Cheese and Nutricima.
Segmental analysis is contained in Table 2 above and further more detailed information on divisional results in the operations reviews.
In August 2008 the Group completed the acquisition of Optimum for a total consideration of 217.9 million (US$323.0 million). This was funded from the Group's existing bank facilities.
During the year Glanbia continued its strategic capital investment programme with 63.4 million expenditure focused mainly on Food Ingredients and Nutritionals. In the two-year period since 2007, the Group has invested a total of 351.0 million on acquisitions and development capital expenditure.
Net debt increased 231.9 million in the year to 452.1 million (2007: 220.2 million) primarily due to the acquisition of Optimum.
The Group generated good free cash flow of 72.4 million in 2008, (2007: 53.1 million). A summary 2008 cash flow is contained in Table 3. Free cash flow is after charging business sustaining capital expenditure and before acquisition costs, strategic capital expenditure and the payment of equity dividends.
The Group has total debt facilities of 661.5 million - bank facilities of 598.0 million and 63.5 million cumulative redeemable preference shares. Bank facilities are held with nine banks under bilateral arrangements with common documentation and terms.
30.0 million of the facilities are renewable in December 2009, 158 million in July 2012 and 410 million in July 2013. The cumulative redeemable preference shares mature in July 2014.Glanbia manages its bank debt position within a number of financial covenants. The key covenants are:
Group Treasury monitors compliance with all financial covenants and recent trends in these ratios are outlined in Table 4.
For financial prudence Glanbia sets more stringent internal net debt to EBITDA targets to recognise that the Group's net debt is subject to seasonal fluctuations and as a result average debt can be up to 30% above year-end debt levels.
In light of the above, the Directors of Glanbia have a reasonable expectation that the Group has adequate resources to operate for the foreseeable future. Therefore they continue to adopt the going concern basis in the preparation of this Annual Report.
The equity of the Group decreased 6.7 million to 227.9 million at the end of the year (2007: 234.6 million). Retained earnings in 2008 decreased 1.5 million as retained profits of 78.4 million were offset by adverse reserve movements due to the increase in the pension deficit.
Glanbia operates defined contribution and defined benefit pension schemes in Ireland and the UK and defined contribution schemes in the USA and other international locations. The deficit in the Group's defined benefit pension schemes increased at the year-end by 50.2 million to 164.4 million (2007: 114.2 million). The deficit on the Irish schemes at year-end amounted to 142.2 million and 22.2 million related to UK schemes. This total deficit was adversely impacted in the year by a negative return on pension fund assets and an enhancement in the actuarial assumptions used in the calculation of the pension liabilities. A review of the funding deficit of the Irish schemes is currently underway as the 10-year funding proposal submitted to the Irish Pensions Board is not currently on track due to low investment returns in 2008. The Group operates defined benefit pension schemes in the UK that relate to UK liquid milk businesses which were disposed of in 1999. Funding is in place to fund the deficit of the UK pension schemes over a 10-year period.
The conduct of Glanbia's ordinary business operations necessitates the holding and issuing of financial instruments and derivative financial instruments by the Group. The main risks, arising from issuing, holding and managing these financial instruments, typically include liquidity risk, interest rate risk and currency risk. The Group's approach is to centrally manage these risks against comprehensive policy guidelines. The Board agrees and regularly reviews these guidelines and more detailed information on financial risk is contained in Note 3.1 'Financial risk factors' in the notes to the financial statements and in the Risk and risk management section.
| 2008 'm |
2007 'm |
|
|---|---|---|
| EBITDA pre exceptional | 167.6 | 149.2 |
| Working capital movement | 0.5 | (39.1) |
| Net interest and taxation paid | (49.7) | (20.0) |
| Additional pension contributions | (14.0) | (11.0) |
| Business sustaining capital investment | (23.6) | (20.8) |
| Other | (8.4) | (5.2) |
| Free cashflow | 72.4 | 53.1 |
| Acquisitions | (229.4) | (19.7) |
| Disposals | 22.2 | 18.4 |
| Strategic capital expenditure | (63.4) | (38.5) |
| Equity dividends | (18.5) | (17.3) |
| Currency exchange/fair value adjustments | (15.2) | 8.2 |
| Net (increase)/decrease in debt during the year | (231.9) | 4.2 |
| Net debt at beginning of the year | (220.2) | (224.4) |
| Net debt at end of the year | (452.1) | (220.2) |
| 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|
| Net debt : EBITDA (times) | 2.7 | 1.5 | 2.0 | 2.1 |
| EBITDA : Net finance cost (times) | 7.9 | 8.6 | 8.1 | 8.2 |
| EBIT: Net finance cost (times) | 6.4 | 6.7 | 6.1 | 6.2 |
Glanbia operates an active domestic and international Investor Relations and Financial Media Relations Programme each year. Glanbia plc is a subsidiary of Glanbia Co-operative Society Limited, an Irish industrial and provident society, which owns 54.6% of the Company.
The remaining 45.4% free float is well balanced between institutional and retail investor ownership and between domestic and international institutional ownership. In 2008, management met with over 190 existing and potential investors.
This will be my last finance review as I am retiring from Glanbia on 30 June 2009. I would like to take this opportunity to express my thanks to John Moloney and all the team at Glanbia. It has been a wonderful privilege to work with a great group of people and I wish them continued success in the future.
Glanbia delivered a strong set of results in 2008 and the Group is well positioned for a challenging 2009. Glanbia has prioritised debt reduction for 2009, recognising the significant investment made in recent years and the current turmoil in global credit markets. The Group will concentrate on the opportunities for organic growth that exist within the current business, as a prudent and conservative approach to reduce capital and operating spend is consistent with the challenging external environment.

Geoff Meagher
Deputy Group Managing Director
Group Finance Director